Feredun Azari

University of Pennsylvania

Papers

2

Total Citations

15

H-Index

2

About

Feredun Azari is a pioneering thoracic surgeon and researcher whose work centers on intraoperative molecular imaging (IMI) and its application in robotic pulmonary surgery. His major contributions lie in developing and clinically validating targeted fluorescent tracers to visualize occult cancers during minimally invasive procedures. In his landmark first-in-human study (2022), Azari demonstrated that IMI can successfully identify ground glass opacities during robot-assisted thoracic surgery (RATS), achieving 12 citations and establishing a new paradigm for real-time tumor detection. His subsequent work on cathepsin-activated probes like VGT-309 (2023) further advanced the field by enabling specific identification of malignant cells through enzymatic activation, with near-infrared light revealing otherwise invisible tumor margins. These innovations directly address the critical challenge of locating non-palpable lesions during surgery, potentially reducing incomplete resections. Azari’s research bridges molecular biology and surgical oncology, offering a tangible path toward more precise, patient-specific cancer care. His work has been recognized for its translational impact, positioning him as a leader in the emerging field of fluorescence-guided thoracic surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
15
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
First-in-human results of targeted intraoperative molecular imaging for visualization of ground glass opacities during robotic pulmonary resection
12 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: University of Pennsylvania

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago